Editorial: An ATRA oddity: new questions revealed on retinoid synthesis in bone marrow cells.

J Leukoc Biol

Department of Biological Sciences, Biomedical Engineering and Biotechnology Program, University of Massachusetts Lowell, Lowell, Massachusetts, USA

Published: June 2016

Download full-text PDF

Source
http://dx.doi.org/10.1189/jlb.3CE0116-030RDOI Listing

Publication Analysis

Top Keywords

editorial atra
4
atra oddity
4
oddity questions
4
questions revealed
4
revealed retinoid
4
retinoid synthesis
4
synthesis bone
4
bone marrow
4
marrow cells
4
editorial
1

Similar Publications

Following the publication of the above article, the authors contacted the Editorial Office to explain that they had identified a pair of duplicate images in the control (Vehicle) group of mouse images in Fig. 1A on p. 1792.

View Article and Find Full Text PDF

Natural products as potential drug treatments for acute promyelocytic leukemia.

Chin Med

April 2024

School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.

Acute promyelocytic leukemia (APL), which was once considered one of the deadliest types of leukemia, has become a curable malignancy since the introduction of all-trans retinoic acid (ATRA) and arsenic trioxide (ATO) as clinical treatments. ATO, which has become the first-line therapeutic agent for APL, is derived from the natural mineral product arsenic, exemplifying an important role of natural products in the treatment of APL. Many other natural products, ranging from small-molecule compounds to herbal extracts, have also demonstrated great potential for the treatment and adjuvant therapy of APL.

View Article and Find Full Text PDF

Background: Little is known on how metabolic reprogramming potentially prompts transition of activated and resting CD4 memory T cells infiltration in tumor microenvironment of gastric cancer (GC). The study aimed to evaluate their interactions and develop a risk model for predicting prognosis in GC.

Methods: Expression profiles were obtained from TCGA and GEO databases.

View Article and Find Full Text PDF

Hemocompatibility of all-trans retinoic acid-loaded citrate polymer coatings for vascular stents.

Regen Eng Transl Med

December 2022

Univeristy of Florida, Materials Science and Engineering, Gainesville, FL, USA.

Purpose: Current strategies implementing drug-eluting polymer stent coatings fail to fully address the lasting effects of endothelial suppression which ultimately result in delayed reendothelialization and thrombogenic complications. The present study investigates the hemocompatibility of all-trans retinoic acid loaded poly (1,8-octanediol-co-citrate) coatings (AtRA-POC coatings) for advanced intravascular stent technology. The ability of these materials in supporting endothelial restoration via migration and proliferation while inhibiting smooth muscle cell growth is also explored.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!